News room
Latest news and updates
We are engaged in multiple public, private, and academic clinical projects on a daily basis, contributing to the development of innovative medical solutions to those in need. Here, we publish news and highlights of our projects and activities, offering you an up-to-date perspective on our company.
26 Mar 2024 InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline CR2O Company Updates, Press...
15 Feb 2024 Biointelect and CR2O forge new strategic partnership to provide advanced end-to-end commercialisation solutions for the...
10 Oct 2023 CEPI to invest up to $25.9 million, with support from the EU, in trials in East Africa to assess a vaccine candidate against...
21 May 2023 CR2O and Artemis Bioservices successfully continue their well-established cooperation CR2O Company Updates Artemis, Bioservices...
29 Mar 2023 CR2O and 3D-PharmXchange are celebrating and securing their successful ongoing collaboration CR2O Company Updates 3D-PharmXchange,...
26 Jan 2023 Initiation of the First-in-Human trial with Dyadic’s SARS-CoV-2-RBD vaccine candidate DYAI-100 CR2O Press Releases C1,...
24 Aug 2022 LARISSA consortium reaches milestone: Novel Rift Valley fever vaccine dosed in Phase I human trial CR2O Project Updates...
29 Jul 2022 First clinical trial authorisation under ECTR is a fact CR2O Project Updates Bunyavax, CEPI, Immunology, Vaccines The clinical...
22 Apr 2022 Freya Pharma Solutions to start pivotal Phase III study with CR2O as clinical operational partner CR2O Press Releases,...
19 Apr 2021 Citryll to start first-in-human studies with CR2O as clinical operations partner CR2O Press Releases, Project Updates autoimmune,...
21 May 2023 CR2O to manage First-in-Human trial with Dyadic’s SARS-CoV-2-S-RBD vaccine candidate DYAI-100 CR2O Press Releases C1, COVID-19,...
01 Dec 2020 CR2O profiled in Biotech NEWS and Life Sciences CR2O Company Updates 19, Biotech NEWS, Interview, Magazine, Winter 2020...
07 Nov 2020 H2020 awards contract to ENDFLU, CR2O coordinated vaccine trial CR2O Press Releases, Project Updates ENDFLU, EU, Hannover,...
10 Jun 2020 GLORIA aims to prove chronic low dose glucocorticoids are highly effective and safe in elderly patients CR2O Press Releases,...
09 Apr 2020 H2020 awards contract to develop a monoclonal antibody against COVID-19 CR2O Press Releases, Project Updates COVID-19,...
05 Mar 2020 Update COVID-19: Safeguarding health and safety CR2O Company Updates, Press Releases COVID-19 As a result of the COVID-19...
09 Jan 2020 ISOLDA aims at the development of improved vaccines against viral infections for older adults CR2O Press Releases, Project...
05 Aug 2019 CEPI awards contract worth up to US$12.5 million to consortium led by Wageningen Bioveterinary Research to develop a human...
